239 related articles for article (PubMed ID: 21333016)
1. Genome-wide expression patterns associated with oncogenesis and sarcomatous transdifferentation of cholangiocarcinoma.
Seol MA; Chu IS; Lee MJ; Yu GR; Cui XD; Cho BH; Ahn EK; Leem SH; Kim IH; Kim DG
BMC Cancer; 2011 Feb; 11():78. PubMed ID: 21333016
[TBL] [Abstract][Full Text] [Related]
2. Genetic and expression alterations in association with the sarcomatous change of cholangiocarcinoma cells.
Yoo HJ; Yun BR; Kwon JH; Ahn HS; Seol MA; Lee MJ; Yu GR; Yu HC; Hong B; Choi K; Kim DG
Exp Mol Med; 2009 Feb; 41(2):102-15. PubMed ID: 19287191
[TBL] [Abstract][Full Text] [Related]
3. Global alterations of DNA methylation in cholangiocarcinoma target the Wnt signaling pathway.
Goeppert B; Konermann C; Schmidt CR; Bogatyrova O; Geiselhart L; Ernst C; Gu L; Becker N; Zucknick M; Mehrabi A; Hafezi M; Klauschen F; Stenzinger A; Warth A; Breuhahn K; Renner M; Weichert W; Schirmacher P; Plass C; Weichenhan D
Hepatology; 2014 Feb; 59(2):544-54. PubMed ID: 24002901
[TBL] [Abstract][Full Text] [Related]
4. Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma.
Wu X; Xia M; Chen D; Wu F; Lv Z; Zhan Q; Jiao Y; Wang W; Chen G; An F
Tumour Biol; 2016 Nov; 37(11):15019-15029. PubMed ID: 27658773
[TBL] [Abstract][Full Text] [Related]
5. Differential gene expression profiling of cultured neu-transformed versus spontaneously-transformed rat cholangiocytes and of corresponding cholangiocarcinomas.
Dumur CI; Campbell DJ; DeWitt JL; Oyesanya RA; Sirica AE
Exp Mol Pathol; 2010 Dec; 89(3):227-35. PubMed ID: 20816680
[TBL] [Abstract][Full Text] [Related]
6. Activation of Notch signaling is required for cholangiocarcinoma progression and is enhanced by inactivation of p53 in vivo.
El Khatib M; Bozko P; Palagani V; Malek NP; Wilkens L; Plentz RR
PLoS One; 2013; 8(10):e77433. PubMed ID: 24204826
[TBL] [Abstract][Full Text] [Related]
7. Suppression of intrahepatic cholangiocarcinoma cell growth by SKI via upregulation of the CDK inhibitor p21.
Kawamura E; Matsubara T; Daikoku A; Deguchi S; Kinoshita M; Yuasa H; Urushima H; Odagiri N; Motoyama H; Kotani K; Kozuka R; Hagihara A; Fujii H; Uchida-Kobayashi S; Tanaka S; Takemura S; Iwaisako K; Enomoto M; Taguchi YH; Tamori A; Kubo S; Ikeda K; Kawada N
FEBS Open Bio; 2022 Dec; 12(12):2122-2135. PubMed ID: 36114826
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-144 suppresses cholangiocarcinoma cell proliferation and invasion through targeting platelet activating factor acetylhydrolase isoform 1b.
Yang R; Chen Y; Tang C; Li H; Wang B; Yan Q; Hu J; Zou S
BMC Cancer; 2014 Dec; 14():917. PubMed ID: 25479763
[TBL] [Abstract][Full Text] [Related]
9. ANXA8 down-regulation by EGF-FOXO4 signaling is involved in cell scattering and tumor metastasis of cholangiocarcinoma.
Lee MJ; Yu GR; Yoo HJ; Kim JH; Yoon BI; Choi YK; Kim DG
Gastroenterology; 2009 Sep; 137(3):1138-50, 1150.e1-9. PubMed ID: 19376120
[TBL] [Abstract][Full Text] [Related]
10. A fibrous stromal component in hepatocellular carcinoma reveals a cholangiocarcinoma-like gene expression trait and epithelial-mesenchymal transition.
Seok JY; Na DC; Woo HG; Roncalli M; Kwon SM; Yoo JE; Ahn EY; Kim GI; Choi JS; Kim YB; Park YN
Hepatology; 2012 Jun; 55(6):1776-86. PubMed ID: 22234953
[TBL] [Abstract][Full Text] [Related]
11. Array comparative genomic hybridization identifies novel potential therapeutic targets in cholangiocarcinoma.
McKay SC; Unger K; Pericleous S; Stamp G; Thomas G; Hutchins RR; Spalding DR
HPB (Oxford); 2011 May; 13(5):309-19. PubMed ID: 21492330
[TBL] [Abstract][Full Text] [Related]
12. A novel three‑miRNA signature predicts survival in cholangiocarcinoma based on RNA‑Seq data.
Cao J; Sun L; Li J; Zhou C; Cheng L; Chen K; Yan B; Qian W; Ma Q; Duan W
Oncol Rep; 2018 Sep; 40(3):1422-1434. PubMed ID: 29956786
[TBL] [Abstract][Full Text] [Related]
13. The mechanism of ATF3 repression of epithelial-mesenchymal transition and suppression of cell viability in cholangiocarcinoma via p53 signal pathway.
You Z; Xu J; Li B; Ye H; Chen L; Liu Y; Xiong X
J Cell Mol Med; 2019 Mar; 23(3):2184-2193. PubMed ID: 30648816
[TBL] [Abstract][Full Text] [Related]
14. Aberrant promoter CpG islands methylation of tumor suppressor genes in cholangiocarcinoma.
Uhm KO; Lee ES; Lee YM; Kim HS; Park YN; Park SH
Oncol Res; 2008; 17(4):151-7. PubMed ID: 18773859
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA profiling of human intrahepatic cholangiocarcinoma cell lines reveals biliary epithelial cell-specific microRNAs.
Kawahigashi Y; Mishima T; Mizuguchi Y; Arima Y; Yokomuro S; Kanda T; Ishibashi O; Yoshida H; Tajiri T; Takizawa T
J Nippon Med Sch; 2009 Aug; 76(4):188-97. PubMed ID: 19755794
[TBL] [Abstract][Full Text] [Related]
16. p38delta/MAPK13 as a diagnostic marker for cholangiocarcinoma and its involvement in cell motility and invasion.
Tan FL; Ooi A; Huang D; Wong JC; Qian CN; Chao C; Ooi L; Tan YM; Chung A; Cheow PC; Zhang Z; Petillo D; Yang XJ; Teh BT
Int J Cancer; 2010 May; 126(10):2353-61. PubMed ID: 19816939
[TBL] [Abstract][Full Text] [Related]
17. PTEN and PDCD4 are bona fide targets of microRNA-21 in human cholangiocarcinoma.
Liu CZ; Liu W; Zheng Y; Su JM; Li JJ; Yu L; He XD; Chen SS
Chin Med Sci J; 2012 Jun; 27(2):65-72. PubMed ID: 22770403
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of 14-3-3ζ expression in intrahepatic cholangiocarcinoma and its clinical implications.
Zhang C; Liu LX; Dong ZR; Shi GM; Cai JB; Zhang PF; Ke AW; Yu JX; Zhou J; Fan J
Tumour Biol; 2015 Mar; 36(3):1781-9. PubMed ID: 25391422
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) is associated with enhanced expression of matrix metalloproteinases and cholangiocarcinoma metastases.
Namwat N; Puetkasichonpasutha J; Loilome W; Yongvanit P; Techasen A; Puapairoj A; Sripa B; Tassaneeyakul W; Khuntikeo N; Wongkham S
J Gastroenterol; 2011 May; 46(5):664-75. PubMed ID: 21076843
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide analysis of gene expression in human intrahepatic cholangiocarcinoma.
Obama K; Ura K; Li M; Katagiri T; Tsunoda T; Nomura A; Satoh S; Nakamura Y; Furukawa Y
Hepatology; 2005 Jun; 41(6):1339-48. PubMed ID: 15880566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
